Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer
- 1 May 2001
- journal article
- Published by Elsevier BV in Surgery
- Vol. 129 (5), 552-558
- https://doi.org/10.1067/msy.2001.112592
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young AdultsThyroid®, 2000
- Vascular endothelial growth factor–C gene expression in papillary and follicular thyroid carcinomasSurgery, 1999
- Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological FeaturesThe American Journal of Pathology, 1999
- Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasmsHuman Pathology, 1999
- Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinomaJournal of Endocrinology, 1999
- Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in AngiogenesisPublished by Springer Science and Business Media LLC ,1999
- Vascular endothelial growth factorThe International Journal of Biochemistry & Cell Biology, 1998
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerAmerican Journal Of Medicine, 1994
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992